West Pharmaceutical Services Inc (WST)
385.73
-4.47
(-1.15%)
USD |
NYSE |
Apr 24, 16:00
385.60
-0.13
(-0.03%)
After-Hours: 20:00
West Pharmaceutical Services Revenue (Quarterly): 732.00M for Dec. 31, 2023
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 732.00M |
| September 30, 2023 | 747.40M |
| June 30, 2023 | 753.80M |
| March 31, 2023 | 716.60M |
| December 31, 2022 | 708.70M |
| September 30, 2022 | 686.90M |
| June 30, 2022 | 771.30M |
| March 31, 2022 | 720.00M |
| December 31, 2021 | 730.80M |
| September 30, 2021 | 706.50M |
| June 30, 2021 | 723.60M |
| March 31, 2021 | 670.70M |
| December 31, 2020 | 580.20M |
| September 30, 2020 | 548.00M |
| June 30, 2020 | 527.20M |
| March 31, 2020 | 491.50M |
| December 31, 2019 | 470.60M |
| September 30, 2019 | 456.10M |
| June 30, 2019 | 469.70M |
| March 31, 2019 | 443.50M |
| December 31, 2018 | 422.50M |
| September 30, 2018 | 431.70M |
| June 30, 2018 | 447.50M |
| March 31, 2018 | 415.70M |
| December 31, 2017 | 415.60M |
| Date | Value |
|---|---|
| September 30, 2017 | 398.20M |
| June 30, 2017 | 397.60M |
| March 31, 2017 | 387.70M |
| December 31, 2016 | 382.30M |
| September 30, 2016 | 376.70M |
| June 30, 2016 | 388.00M |
| March 31, 2016 | 362.10M |
| December 31, 2015 | 359.70M |
| September 30, 2015 | 344.50M |
| June 30, 2015 | 359.70M |
| March 31, 2015 | 335.90M |
| December 31, 2014 | 349.80M |
| September 30, 2014 | 355.90M |
| June 30, 2014 | 368.90M |
| March 31, 2014 | 346.80M |
| December 31, 2013 | 342.70M |
| September 30, 2013 | 341.80M |
| June 30, 2013 | 344.50M |
| March 31, 2013 | 339.40M |
| December 31, 2012 | 321.50M |
| September 30, 2012 | 303.80M |
| June 30, 2012 | 324.80M |
| March 31, 2012 | 316.30M |
| December 31, 2011 | 295.40M |
| September 30, 2011 | 293.60M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
456.10M
Minimum
Sep 2019
771.30M
Maximum
Jun 2022
642.72M
Average
706.50M
Median
Sep 2021
Revenue (Quarterly) Benchmarks
| Becton Dickinson & Co | 4.706B |
| Abbott Laboratories | 9.964B |
| Masimo Corp | 548.90M |
| Merit Medical Systems Inc | 324.52M |
| Insulet Corp | 509.80M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | 137.00M |
| Total Expenses (Quarterly) | 562.20M |
| EPS Diluted (Quarterly) | 1.83 |
| Enterprise Value | 27.59B |
| Gross Profit Margin (Quarterly) | 38.01% |
| Profit Margin (Quarterly) | 18.72% |
| Earnings Yield | 2.04% |
| Operating Earnings Yield | 2.44% |
| Normalized Earnings Yield | 2.132 |